Adenovirus early region 3(E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice

Area of Science:

• Immunology
• Endocrinology
• Virology

Background:

• Adenovirus (Ad) early three (E3) region proteins modulate host immune responses.
• E3 proteins interfere with antigen presentation and apoptosis.
• Autoimmune diabetes in nonobese diabetic (NOD) mice involves immune-mediated beta-cell destruction.

Purpose of the Study:

• To investigate the therapeutic potential of Ad E3 gene expression in beta-cells for autoimmune diabetes.
• To determine the effect of E3 gene expression on immune cell infiltration and beta-cell destruction in NOD mice.

Main Methods:

• Transgenic expression of Ad E3 genes in mouse beta-cells using the rat insulin II promoter (RIP-E3).
• Generation of RIP-E3/NOD mice and assessment of autoimmune diabetes incidence and onset.
• Adoptive transfer experiments using immune effector cells from RIP-E3/NOD mice and wild-type NOD mice.

Main Results:

• RIP-E3/NOD mice exhibited decreased incidence and delayed onset of autoimmune diabetes.
• Immune effector cells from RIP-E3/NOD mice showed reduced capacity to transfer diabetes.
• Adoptive transfer of wild-type NOD splenocytes into RIP-E3/NOD mice resulted in delayed hyperglycemia and protection in 40% of recipients.

Conclusions:

• Expression of Ad E3 genes in beta-cells confers resistance to autoimmune destruction.
• Ad E3 gene expression influences both immune effector cell activation and intrinsic beta-cell resilience.
• Targeting beta-cell E3 gene expression may represent a novel strategy for managing autoimmune diabetes.